Should You Really Buy Stocks With the S&P 500 Near Its Record High? Historical Data Gives a Clear Answer.

The S&P 500 has rebounded to a new record high after being 9% below its peak on March 30, even as Middle East tensions and inflation pressures persist. Wall Street’s bottom-up forecast now implies 17% upside over the next year to 8,326, but the index also trades at 21.1x forward earnings versus a 5-year average of 19.9x, leaving valuations elevated. The article is broadly constructive on long-term returns from highs, but it urges caution given rising gasoline prices and March CPI at 3.3% with April trending toward 3.6%.

Analysis

The important signal here is not that equities are at highs; it’s that the market is refusing to price in the macro shock that usually follows an oil/inflation flare-up. That tells us positioning and buyback demand are still overpowering macro fear, but it also leaves the index vulnerable to a fast sentiment reset if inflation prints stay sticky for another 1-2 months. In that regime, leadership matters more than the index level: crowded mega-cap quality can keep levitating while cyclicals and rate-sensitive software quietly underperform.

The second-order winner is not the broad index, but firms with durable pricing power and light energy sensitivity. Tech and healthcare should continue to attract flows because they combine secular earnings growth with relatively cleaner margin protection if gasoline and freight costs bleed into consumer demand. By contrast, the most fragile exposures are consumer discretionary, transports, and lower-quality industrials where consensus EPS already assumes stable margins and no further input-cost shock.

The contrarian read is that “record highs are bullish” is statistically true but tactically incomplete. The distribution of outcomes likely bifurcates: either inflation moderates quickly and the market grinds higher, or a few more hot prints force rates higher and compress multiples before earnings can catch up. With the index already trading above its five-year forward multiple average, the asymmetry favors hedging expensive beta rather than fighting the tape outright.

For the named stocks, NVDA and INTC are being pulled into the same AI infrastructure narrative, but their risk is very different: NVDA is mostly a demand-duration story, while INTC is a capex-execution and share-gain story that can disappoint even if the sector stays strong. FDS is more of a valuation/quality proxy on market data demand and should hold up better than the index in a choppier tape; NFLX is less sensitive to inflation than ad-dependent media and should benefit if consumers trade down toward home entertainment. None are obvious shorts, but the market is not paying for much disappointment.

Key Decisions for Investors

• Buy VGT vs. SPY on a 1-3 month horizon: long tech quality as the cleanest hedge against sticky inflation; target 1.3-1.5x relative performance if rates stabilize, with downside limited to broad market drawdown risk.
• Use SPY put spreads 5-8% out-of-the-money for the next CPI/FOMC window: cheap convexity against a two-print inflation reversal that could compress the index multiple before earnings revisions roll over.
• Pair long FDS / short XLY for the next 6-12 weeks: quality market-data demand should outperform consumer discretionary if gasoline keeps squeezing real spending; risk is a quick disinflation relief rally.
• Stay long NVDA, but hedge with a partial INTC short only as a relative-value expression, not outright beta short: NVDA has stronger pricing power, while INTC remains more execution-sensitive; use a 3-6 month horizon.
• Avoid adding broad index beta at current levels; if forced to add risk, scale into healthcare via VHT rather than SPY, since it offers better earnings visibility with less exposure to macro demand deterioration.